Proteomic and functional analyses demonstrate the involvement of oxidative stress in the anticancer activities of oridonin in HepG2 cells

Wang,Hui; Ye,Yan; Yu,Zhi-Ling

doi:10.3892/or.2014.3081

Proteomic and functional analyses demonstrate the involvement of oxidative stress in the anticancer activities of oridonin in HepG2 cells

Authors:
- Hui Wang
- Yan Ye
- Zhi-Ling Yu
View Affiliations

Affiliations: Guangdong Provincial Key Laboratory of Biotechnology Candidate Drug Research, School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, P.R. China, Center for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, SAR, P.R. China
Published online on: March 12, 2014 https://doi.org/10.3892/or.2014.3081
Pages: 2165-2172

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oridonin exhibits a curative effect on liver carcinoma in patients and experimental animals. In the present study, we performed proteomic and functional analyses to explore the mechanism involved in the anticancer activity of oridonin. Oridonin treatment for 24 h resulted in a dose-dependent decrease in cell viability with an IC50 value of 37.90 µM. Treatment with 40 µM oridonin for 24 h induced apoptosis as typical apoptotic nuclear alterations were observed following DAPI staining. Using a 2-DE-based proteomic approach, 3 upregulated oxidative stress markers, Hsp70-1, Hop and Prdx2, were identified in the HepG2 cells treated with 40 µM oridonin for 24 h. A pattern of alteration in Hsp70-1 was verified by western blotting. The mRNA expression patterns of Hsp70-1 and Hop as determined by qPCR were comparable to their protein expression patterns. Further investigations showed that oridonin treatment for 24 h resulted in reactive oxygen species (ROS) generation, and ROS scavenger N-acetylcysteine (NAC) completely inhibited ROS production and restored cell viability, suggesting that oxidative stress contributed to oridonin-induced HepG2 cell death. Western blot analysis of oxidative stress pathway-related proteins demonstrated that oridonin treatment increased p-JNK, p-p38 and p-p53, and decreased Bcl-2 protein expression levels, promoted cytochrome c release, decreased mitochondrial membrane potential, and activated caspase-9 and caspase-3. Furthermore, knockdown of Hsp70-1 expression with specific shRNA significantly decreased the viability of the cells treated with oridonin, suggesting a protective role of Hsp70-1 in oridonin-mediated oxidative stress. The results of the present study provide evidence for a link between oxidative stress and oridonin-induced apoptosis in HepG2 cells.

View Figures

View References

1	Gao X, Liu SZ, Liu QL, Liu YY, Zeng DL and Deng MD: Clinical study on anti-cancer effects of Rabdosia rubescens. Chin J Cancer. 3:201–202. 1984.
2	Zhang JF, Chen GH, Lu MQ and Liu JJ: Antiproliferation effects of oridonin on hepatocellular carcinoma BEL-7402 cells and its mechanism. Chin Traditional Patent Med. 28:1325–1329. 2006.
3	Huang J, Wei XY, Sun BH, Wu LJ and Ikejima T: Oridonin induced HepG2 cell death partially through TNFα signal pathway. Modern Chin Med. 12:28–32. 2010.
4	Cai DT, Jin H, Xiong QX, et al: ER stress and ASK1-JNK activation contribute to oridonin-induced apoptosis and growth inhibition in cultured human hepatoblastoma HuH-6 cells. Mol Cell Biochem. 379:161–169. 2013. View Article : Google Scholar : PubMed/NCBI
5	Wang RL: Therapeutic effects of Isodon rubescens and oridonin preparations in 31 patients with primary carcinoma of the liver. Ai Zheng. 3:501984.
6	Ha HL, Shin HJ, Feitelson MA and Yu DY: Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol. 16:6035–6043. 2010. View Article : Google Scholar : PubMed/NCBI
7	Morales-González JA: Oxidative Stress and Chronic Degenerative Diseases - A Role for Antioxidants. InTech. http://dx.doi.org/10.5772/45722. View Article : Google Scholar
8	Fang J, Nakamura H and Iyer AK: Tumor-targeted induction of oxystress for cancer therapy. J Drug Target. 15:475–486. 2007. View Article : Google Scholar : PubMed/NCBI
9	Trachootham D, Alexandre J and Huang P: Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 8:579–591. 2009. View Article : Google Scholar : PubMed/NCBI
10	Papp E, Nardai G, Soti C and Csermely P: Molecular chaperones, stress proteins and redox homeostasis. Biofactors. 17:249–257. 2003. View Article : Google Scholar : PubMed/NCBI
11	Odunuga OO, Longshaw VM and Blatch GL: Hop: more than an Hsp70/Hsp90 adaptor protein. Bioessays. 26:1058–1068. 2004. View Article : Google Scholar : PubMed/NCBI
12	Kang SW, Chae HZ, Seo MS, Kim K, Baines IC and Rhee SG: Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J Biol Chem. 273:6297–6302. 1998.PubMed/NCBI
13	Kim H, Lee TH, Park ES, et al: Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem. 275:18266–18270. 2000. View Article : Google Scholar : PubMed/NCBI
14	Fratelli M, Demol H, Puype M, et al: Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc Natl Acad Sci USA. 99:3505–3510. 2002. View Article : Google Scholar : PubMed/NCBI
15	Paron I, D’Elia A, D’Ambrosio C, et al: A proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells. Biochem J. 378:929–937. 2004. View Article : Google Scholar : PubMed/NCBI
16	Cesaratto L, Vascotto C, D’Ambrosio C, et al: Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver. Free Radic Res. 39:255–268. 2005. View Article : Google Scholar : PubMed/NCBI
17	Wang T, Tamae D, LeBon T, Shively JE, Yen Y and Li JJ: The role of peroxiredoxin II in radiation-resistant MCF-7 breast cancer cells. Cancer Res. 65:10338–10346. 2005. View Article : Google Scholar : PubMed/NCBI
18	Pan JS, Hong MZ and Ren JL: Reactive oxygen species: a double-edged sword in oncogenesis. World J Gastroenterol. 15:1702–1707. 2009. View Article : Google Scholar : PubMed/NCBI
19	Wu GS: The functional interactions between the p53 and MAPK signaling pathways. Cancer Biol Ther. 3:156–161. 2004. View Article : Google Scholar : PubMed/NCBI
20	Shen Y and White E: p53-dependent apoptosis pathways. Adv Cancer Res. 82:55–84. 2001. View Article : Google Scholar
21	Wang H, Ye Y, Chui JH, et al: Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells. Oncol Rep. 24:647–651. 2010.PubMed/NCBI
22	Zhang JF, Liu JJ, Liu PQ, Lin DJ, Li XD and Chen GH: Oridonin inhibits cell growth by induction of apoptosis on human hepatocelluar carcinoma BEL-7402 cells. Hepatol Res. 35:104–110. 2006. View Article : Google Scholar : PubMed/NCBI
23	Wang H, Ye Y, Chu JH, Zhu GY, Fong WF and Yu ZL: Proteomic and functional analyses reveal the potential involvement of endoplasmic reticulum stress and α-CP1 in the anticancer activities of oridonin in HepG2 cells. Integr Cancer Ther. 10:160–167. 2010.PubMed/NCBI
24	Zhang JF, Chen GH, Lu MQ, Li H, Cai CJ and Yang Y: Change of Bcl-2 expression and telomerase during apoptosis induced by oridonin on human hepatocelluar carcinoma cells. Zhongguo Zhong Yao Za Zhi. 31:1811–1814. 2006.(In Chinese).
25	Yoon SO, Yun CH and Chung AS: Dose effect of oxidative stress on signal transduction in aging. Mech Ageing Dev. 123:1597–1604. 2002. View Article : Google Scholar : PubMed/NCBI
26	Liu J, Shen HM and Ong CN: Role of intracellular thiol depletion, mitochondrial dysfunction and reactive oxygen species in Salvia miltiorrhiza-induced apoptosis in human hepatoma HepG2 cells. Life Sci. 69:1833–1850. 2001. View Article : Google Scholar : PubMed/NCBI
27	Datta K, Babbar P, Srivastava T, Sinha S and Chattopadhyay P: p53 dependent apoptosis in glioma cell lines in response to hydrogen peroxide induced oxidative stress. Int J Biochem Cell Biol. 34:148–157. 2002. View Article : Google Scholar : PubMed/NCBI
28	Haruna S, Kuroi R, Kajiwara K, et al: Induction of apoptosis in HL-60 cells by photochemically generated hydroxyl radicals. Bioorg Med Chem Lett. 12:675–676. 2002. View Article : Google Scholar : PubMed/NCBI
29	Du Y, Villeneuve NF, Wang XJ, et al: Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response. Environ Health Perspect. 116:1154–1161. 2008. View Article : Google Scholar : PubMed/NCBI
30	Zang L, He H, Xu Q, et al: Reactive oxygen species H₂O₂ and radical •OH, but not O2^{• −} promote oridonin-induced phagocytosis of apoptotic cells by human histocytic lymphoma U937 cells. Int Immunopharmacol. 15:414–423. 2013.
31	Cheng Y, Qiu F, Ye YC, et al: Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells. FEBS J. 276:1291–1306. 2009. View Article : Google Scholar
32	Huang J, Wu L, Tashiro S, Onodera S and Ikejima T: Reactive oxygen species mediate oridonin-induced HepG2 apoptosis through p53, MAPK, and mitochondrial signaling pathways. J Pharmacol Sci. 107:370–379. 2008. View Article : Google Scholar : PubMed/NCBI
33	Yu Y, Fan SM, Song JK, Tashiro S, Onodera S and Ikejima T: Hydroxyl radical (•OH) played a pivotal role in oridonin-induced apoptosis and autophagy in human epidermoid carcinoma A431 cells. Biol Pharm Bull. 35:2148–2159. 2012.
34	McCubrey JA, Lahair MM and Franklin RA: Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal. 8:1775–1789. 2006. View Article : Google Scholar : PubMed/NCBI
35	Schuler M and Green DR: Mechanisms of p53-dependent apoptosis. Biochem Soc Trans. 29:684–688. 2001. View Article : Google Scholar : PubMed/NCBI